Nemchenko O. Pharmacoeconomical principles of medical patients with bronchial asthma under health insurance

The thesis presents the results of research on the disease and the current state of pharmaceutical bronchial asthma in the world and Ukraine, as well as the principles of modern concepts of pharmacotherapy indicated pathology. Grounded current organizational and economic approaches to improve pharmaceutical safety of blood for this pathology under health insurance.According to research conducted by the method of modeling the first stage of pharmacotherapy of bronchial asthma with the use of markоv's chains (tested on the example of the results of treatment of patients with stages III and IV combined antiasthmatic drugs Seretyd Evohaler and Simbykort Turbuhaler) pharmacoeconomical analysis of standard basic therapy schemes for complex methods (minimization of costs, cost - effectiveness, benefit - expenses) and on the basis of expert survey of physicians and pulmonary pharmacoeconomical analysis to formulary recommendations and insurance lists antiasthmatic drugs.Past research has helped improve the synthesis by conventional basic therapy of bronchial asthma in adults and children, as well as methods of clinical and economic evaluation of medical appointments during inpatient treatment of bronchial asthma with ABC, VEN and frequency analysis.